European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 3 , Pages 267-273 , September 2007

Medical Management of Abdominal Aortic Aneurysm

  • J. Golledge

      Affiliations

    • Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Australia 4811
    • This author is supported by funding from the National Institute of Health, USA (RO1 HL080010-01) and NHMRC (project grant 379600, fellowship 431503).
    • ,
  • J.T. Powell

      Affiliations

    • Vascular Surgery Research Group, Imperial College at Charing Cross, St Dunstan's Road, London W6 8RP, UK
    • Corresponding Author InformationCorresponding author. Professor J.T. Powell, Vascular Surgery Research Group, Imperial College at Charing Cross, St Dunstan's Road, London W6 8RP, UK.

,Accepted 27 March 2007.

References 

  1. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. Multicentre Aneurysm Screening Study Group The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360(9345):1531–1539
  2. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ. 2005;330(7494):750
  3. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142(3):203–211
  4. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997;126(6):441–449
  5. Boll APM, Verbeek ALM, van de Lisdonk EH, van der Vliet JA. High prevalence of abdominal aortic aneurysm in a primary care screening programme. Br J Surg. 1998;85:1090–1094
  6. Brady AR, Fowkes FG, Thompson SG, Powell JT. Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler Thromb Vasc Biol. 2001;21:1203–1207
  7. Norman P, Le M, Pearce C, Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol. 2004;24:1278–1282
  8. UK Small Aneurysm Trial Participants . The long-term prognosis of patients with small abdominal aortic aneurysms following surgery or surveillance: 12-year final follow-up of patients enrolled in the UK Small Aneurysm Trial. Br J Surg. 2007;94:702–708
  9. Cornuz J, Sidoti Pinto C, Tevaearai H, Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health. 2004;14(4):343–349
  10. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112(6):924–934
  11. Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs. 2006;11(3):429–444
  12. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med. 2004;116:96–103
  13. Leurs LJ, Visser P, Laheij RJ, Buth J, Harris PL, Blankensteijn JD. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular. 2006;14(1):1–8
  14. Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22
  15. Sever P. New hypertension guidelines from the national institute for health and clinical excellence and the British Hypertension Society. J Renin Angiotensin Aldosterone Syst. 2006;7(2):61–63www.nice.org.uk/CG034
  16. Erez G, Leitersdorf E. The rationale for using HMG-CoA reductase inhibitors (statins) in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2007;33(2):192–201
  17. Singer DR. Hypertension, does the choice of drug treatment matter? Eur J Vasc Endovasc Surg, submitted May 2007.
  18. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. REACH Registry Investigators International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–189
  19. Lloyd GM, Newton JD, Norwood MG, Franks SC, Bown MJ, Sayers RD. Patients with AAA: are we missing the opportunity for cardiovascular risk reduction?. J Vasc Surg. 2004;40:691–697
  20. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U, et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg. 2003;38(6):1283–1292
  21. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG EVAR Trial Participants. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364:843–848
  22. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341:1789–1794
  23. POBBLE Trial Investigators . Perioperative blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41:602–609
  24. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. Br Med J. 2006;333:1149–1152
  25. Bickwell WH, Stern S. Fluid replacement for hypotensive injury victims: how, when and what risks?. Curr Opin Anaesthesiol. 1998;11:177–180
  26. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52:1141–1146
  27. Veith FJ, Ohki T, Lipsitz EC, Suggs WD, Cynamon J. Endovascular grafts and other catheter-directed techniques in the management of ruptured abdominal aortic aneurysms. Semin Vasc Surg. 2003;16:326–331
  28. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16–21
  29. Golledge J, Muller J, Daugherty A, Norman P. Abdominal Aortic Aneurysm. Pathogenesis and Implications for Management. Arterioscler Thromb Vasc Biol. 2006;26(12):2605–2613
  30. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006;26(5):987–994
  31. Propanolol Aneurysm Trial Investigators . Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg. 2002;35(1):72–79
  32. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg. 2001;34:606–610
  33. Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg. 2001;88:1066–1072
  34. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW, Kent KC, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg. 2002;36:1–12
  35. Fisher JF, Mobashery S. Recent advances in MMP inhibitor design. Cancer Metastasis Rev. 2006;25:115–136
  36. Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, Dunkelgrun M, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32:21–26
  37. Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006;97(2):279–280
  38. Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM. Simvastatin attenuates the activity of MMP-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg. 2007;94(S1):8–9
  39. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet. 2006;368(9536):659–665
  40. Lederle FA, Taylor BC. ACE Inhibitors and aortic rupture. Lancet. 2006;368(9547):1571
  41. EVAR Trial Participants . Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet. 2005;365(9478):2179–2186
  42. Sangiorgi G, D'Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation. 2001;104(12 Suppl. 1):I288–I295
  43. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med. 2005;11:1330–1338
  44. Nevitt MP, Ballard DJ, Hallet JW. Prognosis of Abdominal Aortic Aneurysms. N Engl J Med. 1989;321:1009–1014
  45. Santilli SM, Littooy FN, Cambria RA, Rapp JH, Tretinyak AS, d'Audiffret AC, et al. Expansion rates and outcomes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg. 2002;35:666–671
  46. Vardulaki KA, Prevost TC, Walker NM, Day NE, Wilmink AB, Quick CR, et al. Growth rates and risk of rupture of abdominal aortic aneurysms. Br J Surg. 1998;85(12):1674–1680
  47. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation. 2004;110:862–866
  48. The UK Small Aneurysm Trial Participants . Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet. 1998;352:1649–1655
  49. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Aneurysm Detection and Management Veterans Affairs Cooperative Study Group Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437–1444

 One of a series of educational articles edited by Janet Powell, UK.

PII: S1078-5884(07)00202-X

doi: 10.1016/j.ejvs.2007.03.006

European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 3 , Pages 267-273 , September 2007

Article Tools

* Image Usage & Resolution